Lena Kanter‐Lewensohn

A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony‐stimulating factor: significant effects on quality of life

Eva Hellström‐Lindberg, Nina Gulbrandsen, Greger Lindberg et al. · British Journal of Haematology · 2003 · 454 citations · Full text

Medicine, Hematology, Pharmacotherapy +16

Treatment of Anemia in Myelodysplastic Syndromes With Granulocyte Colony-Stimulating Factor Plus Erythropoietin: Results From a Randomized Phase II Study and Long-Term Follow-Up of 71 Patients

Eva Hellström-Lindberg, Tomas Ahlgren, Yves Béguin et al. · Blood · 1998 · 306 citations · Full text

Medicine, Hematology, Pharmacotherapy +14

KIT Pathway Alterations in Mucosal Melanomas of the Vulva and Other Sites

Katarina Omholt, Eva Grafström, Lena Kanter‐Lewensohn et al. · Clinical Cancer Research · 2011 · 191 citations

Medicine, Oncology, Pathology +17

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females

Boel Ragnarsson-Olding, Lena Kanter‐Lewensohn, Bengt Lagerl�f et al. · Cancer · 1999 · 184 citations · Full text

Medicine, Oncology, Pathology +17

Malignant melanoma of the vulva in a nationwide, 25-year study of 219 Swedish females

Boel Ragnarsson-Olding, Bo Nilsson, Lena Kanter‐Lewensohn et al. · Cancer · 1999 · 121 citations

Medicine, Oncology, Pathology +17